In person
This year, the FBLD Conference was held in Boston, and ZoBio was excited to be part of this remarkable event. Fragment-Based Lead Discovery (FBLD) continues to grow rapidly as a multidisciplinary field, bringing together experts in chemistry, biochemistry, and related areas to present the latest advancements. We couldn’t miss the opportunity to be there!
Gregg Siegal, CEO of ZoBio, enjoyed connecting with the FBLD community and participating in a high-quality program featuring talks, workshops, poster sessions, and numerous networking opportunities, all centered around the diverse aspects of fragment-based drug discovery.